Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Thyroid Neoplasms × Dexmedetomidine × Clear all

Phase

Phase NA 3 Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 3 Neoplasms 2 Agnosia 2 Thyroid Neoplasms 1 Postoperative Analgesia 1 Pain, Intractable 1 Neoplasm Metastasis 1 Inflammation 1

Interventions

fosbretabulin 1 combretastatin 1 Sodium Iodide 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Iodine-131 1 Iodine-123 1 Dexmedetomidine 1 Carboplatin 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07434206 2026-02-25

Safety and Efficacy of Dexmedetomidine in Controlling Hemodynamics During Resection of Active Thyroid Secreting Tumors

South Egypt Cancer Institute

Phase 2/3 Active not recruiting

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡